Is Tonstakers LSD a Good Investment?

CValue
B-Risk
|Liquid Staking
TVL$61M
FDV
TVL/FDV
Risk GradeB-
Value GradeC

Value Accrual: Does the Tonstakers LSD Token Capture Value?

Tonstakers LSD scores C on Hindenrank's value accrual framework (48/100), indicating average value capture — some strengths offset by weaknesses in fee distribution or sustainability. Fee capture scores 8/25 — limited, with most protocol revenue not yet accruing to the token. Token distribution is rated 10/25 (somewhat concentrated, raising concerns about governance capture), and emission sustainability sits at 16/25. The competitive moat dimension scores 14/25.

Scored as: Business
Fee Capture
8/25
Token Distribution
10/25
Emission Sustainability
16/25
Competitive Moat
14/25

Protocol Health: Is Tonstakers LSD Still Growing?

Tonstakers LSD's vitality risk score is 8/10 on Hindenrank's rubric (lower is healthier). This raises concerns about protocol vitality — Tonstakers LSD shows signs of declining activity, stagnant or falling TVL, or reduced developer engagement. Investors should monitor whether this trend reverses before increasing exposure.

GitHub: tonstakers

Risk-Adjusted View: Is the Upside Worth the Risk?

Risk-Adjusted Position

Safe but Stale
High Value
Medium Value
Low Value
High Risk
High Risk Play
Risky
Avoid
Medium Risk
Promising
Neutral
Weak
Low Risk
Blue Chip
Tonstakers LSD
Dead Money
See all Safe but Stale protocols →

Tonstakers LSD falls in the Safe but Stale zone — low risk (B-) but middling value capture (C). The protocol is well-built and battle-tested, but its token may not capture much upside from growth. This positioning can be appropriate for risk-averse allocators who prioritize capital preservation.

Risk Context

Tonstakers LSD carries a risk grade of B- (28/100), classified as moderate risk — some novel mechanisms, generally well-understood. While no critical-severity interactions were identified, 1 high-severity interaction warrant attention. The primary risk factor is: Dominant 67% market share of TON liquid staking creates systemic concentration risk for the entire TON DeFi ecosystem

Read our full safety analysis →

Should you buy Tonstakers LSD?

Tonstakers LSD scores C on Hindenrank's value accrual framework, placing it among the average Liquid Staking protocols. Fee capture scores 8/25 — limited, with most protocol revenue not yet accruing to the token. Token distribution is somewhat concentrated, raising concerns about governance capture, and emission sustainability sits at 16/25. On the risk side, Tonstakers LSD carries a B- grade (28/100), which is moderate risk — some novel mechanisms, generally well-understood. The combined risk-value position places Tonstakers LSD in the Safe but Stale quadrant.

Tonstakers LSD investment outlook for 2026

With $61M in total value locked, Tonstakers LSD's fundamentals do not strongly support the current valuation from a usage perspective. The competitive moat dimension scores 14/25, suggesting meaningful but not impregnable competitive advantages.Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.

This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology

Weekly Commentary

Pro

Week of March 3, 2026

Tonstakers earns a solid B- risk grade on clean liquid staking mechanics, but the C value score flags weak fee capture and limited competitive moat in TON's still-maturing staking ecosystem. At $56M TVL it's a safe hold, not a conviction bet — the "Safe but Stale" quadrant tag fits a protocol that does its job without offering much upside catalyst. Look for TON ecosystem growth or improved tokenomics before upgrading conviction.

Related Liquid Staking Investment Analyses

Related Liquid Staking Safety Analyses

Investment analysis uses Hindenrank's value accrual framework across four dimensions: fee capture, token distribution, emission sustainability, and competitive moat. Higher score = better value accrual. Combined with our eight-dimension risk rubric for risk-adjusted positioning. This is not financial advice.